following Lilly's off-patent drug Strattera. Perry Sternberg, senior vice president, Neuroscience Business Unit, Shire said having a choice of non-stimulant ADHD treatments was important for ...

People with ADHD who have a history of substance use disorder often take non-stimulant medications to avoid the possibility of addiction or overdose. Let a healthcare provider know if you're ...

A study of people who started ADHD stimulant treatment via telehealth vs in-person visits shows no difference in risk of new substance use disorders except for young adults age 26-34.

While both stimulant and non-stimulant medications are widely used ... calcium channel modulation as the foundation for a new non-stimulant ADHD therapy. These findings not only validate our ...

Adult ADHD has emerged as a significant health concern in the United States, with approximately one-quarter of adults suspecting they may have undiagnosed attention deficit hyperactivity disorder.

Stimulants, in particular, are the most prescribed medication ... People with ADHD, especially those with an inattentive presentation, have been shown to have less BDNF than their non-ADHD peers.

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name ...

we have uncovered a shared metabolic signature across treatments—highlighting the potential of L-type calcium channel modulation as the foundation for a new non-stimulant ADHD therapy. These findings ...